Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Will Sinopharm and CITIC IPO?

publication date: Aug 27, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Last week, The South China Morning Post reported that the China National Pharmaceutical Group (Sinopharm) and CITIC Pharmaceutical Group plan IPOs. The Sinopharm offering would raise up to $750 million. The article said Sinopharm’s IPO would take place in Q4, and the shares would be listed on the Hong Kong exchange. Sinopharm, a state-owned enterprise, is the largest pharmaceutical distribution company in China. Immediately after the item appeared, a spokesperson from Sinopharm denied the report, saying the company hopes to make an IPO eventually, but has not set a definite time. More details...

Stock Symbol: (SH: 600511)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
Shanghai, China
April 14-15, 2015

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors